MetLife Investment Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $338K | Buy |
41,462
+8,451
| +26% | +$68.8K | ﹤0.01% | 1883 |
|
2025
Q1 | $259K | Sell |
33,011
-514
| -2% | -$4.04K | ﹤0.01% | 2060 |
|
2024
Q4 | $499K | Buy |
33,525
+2,521
| +8% | +$37.5K | ﹤0.01% | 1797 |
|
2024
Q3 | $474K | Hold |
31,004
| – | – | ﹤0.01% | 1815 |
|
2024
Q2 | $472K | Buy |
31,004
+2,870
| +10% | +$43.7K | ﹤0.01% | 1747 |
|
2024
Q1 | $531K | Hold |
28,134
| – | – | ﹤0.01% | 1640 |
|
2023
Q4 | $537K | Hold |
28,134
| – | – | ﹤0.01% | 1644 |
|
2023
Q3 | $505K | Hold |
28,134
| – | – | ﹤0.01% | 1629 |
|
2023
Q2 | $571K | Buy |
28,134
+1,203
| +4% | +$24.4K | ﹤0.01% | 1610 |
|
2023
Q1 | $491K | Hold |
26,931
| – | – | ﹤0.01% | 1654 |
|
2022
Q4 | $557K | Buy |
26,931
+480
| +2% | +$9.93K | ﹤0.01% | 1573 |
|
2022
Q3 | $692K | Hold |
26,451
| – | – | 0.01% | 1404 |
|
2022
Q2 | $670K | Buy |
26,451
+1,412
| +6% | +$35.8K | 0.01% | 1461 |
|
2022
Q1 | $790K | Buy |
25,039
+9,127
| +57% | +$288K | 0.01% | 1475 |
|
2021
Q4 | $644K | Hold |
15,912
| – | – | 0.01% | 1367 |
|
2021
Q3 | $555K | Sell |
15,912
-2,486
| -14% | -$86.7K | 0.01% | 1463 |
|
2021
Q2 | $505K | Hold |
18,398
| – | – | ﹤0.01% | 1561 |
|
2021
Q1 | $517K | Hold |
18,398
| – | – | ﹤0.01% | 1504 |
|
2020
Q4 | $478K | Hold |
18,398
| – | – | ﹤0.01% | 1512 |
|
2020
Q3 | $315K | Buy |
18,398
+2,753
| +18% | +$47.2K | ﹤0.01% | 1603 |
|
2020
Q2 | $387K | Hold |
15,645
| – | – | ﹤0.01% | 1521 |
|
2020
Q1 | $217K | Hold |
15,645
| – | – | ﹤0.01% | 1654 |
|
2019
Q4 | $158K | Hold |
15,645
| – | – | ﹤0.01% | 2109 |
|
2019
Q3 | $142K | Hold |
15,645
| – | – | ﹤0.01% | 2136 |
|
2019
Q2 | $124K | Hold |
15,645
| – | – | ﹤0.01% | 2287 |
|
2019
Q1 | $195K | Hold |
15,645
| – | – | ﹤0.01% | 1996 |
|
2018
Q4 | $168K | Buy |
+15,645
| New | +$168K | ﹤0.01% | 1997 |
|